RGS
Click for more information
0.00% 12.0¢ regeneus ltd

Ann: US Patent Office to allow key patent for Progenza, page-8

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. phillip_k
    4,884 Posts.
    lightbulb Created with Sketch. 2
    clock Created with Sketch.
    10/07/18
    15:44
    Post #: 34255593
    RGS' chart and momentum is looking strong. Looks like it is poised for a re-rate on the back of a good clinical agreement coming out of Japan, which as we have been advised can happen in the near term.
    RGS Price at posting: 16.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 
watchlist Created with Sketch. Add RGS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.